INTRAOKULARLINSENINJEKTOR

Patent europeic · EP3556322 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3556322
Numer da la dumonda
EP17884933
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
15-12-2017
Publitgà
23-10-2019
Concedì
23-04-2025
Stritgà
23-07-2026
Motiv
Taxa annuala betg pajada
Classas IPC
A61F 2/16 (2006.01)
Prioritad
JP 2016245504 19.12.2016
JP 2016245505 19.12.2016
Dumonda PCT
PCT/JP2017/045165 15.12.2017
Publicaziun PCT
WO2018/116992 28.06.2018
Lingua da l’annunzia
giapunais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-07-2026

    Stritgà, taxa betg pajada

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.07.2026
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.07.2026

  2. 04-03-2026

    Midada

    Published in Swissreg on 04.03.2026

  3. 23-04-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 23.04.2025

Partidas

Possessur

SANTEN PHARMACEUTICAL CO., LTD.

Santen Pharmaceutical Co., Ltd.

9-19, Shimoshinjo 3-chome, Higashiyodogawa-ku Osaka-shi Osaka 533-8651, JP

Inventur

MATSUMOTO, Kazuma

Osaka-shi Osaka 533-8651, JP

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.